LINQ II Insertable Cardiac Monitor vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

LINQ II Insertable Cardiac Monitor

by Medtronic

DeepRhythmAI

by Medicalgorithmics S.A.

AI Verdict

LINQ II is an insertable cardiac monitor that provides long-term, continuous heart rhythm data collection and initial AI-powered analysis through an implanted device. DeepRhythmAI, conversely, is a cloud-based AI algorithm designed to analyze ECG data from various devices, offering enhanced accuracy and efficiency in arrhythmia detection and classification. While both leverage AI for cardiac arrhythmia, LINQ II focuses on continuous data acquisition via an implanted device, whereas DeepRhythmAI specializes in the advanced analysis of pre-existing ECG data.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous heart rhythm monitoring for infrequent or elusive arrhythmias over several years. Its insertable nature, AI-powered accuracy, and remote programming capabilities make it ideal for sustained diagnostic oversight, even for pediatric patients, while maintaining MRI compatibility.

View LINQ II Insertable Cardiac Monitor →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your practice needs to enhance the speed and accuracy of cardiac arrhythmia detection and classification from existing or newly acquired ECG data. This cloud-based, device-agnostic AI algorithm is best suited for streamlining clinical workflows, reducing diagnostic turnaround times, and significantly minimizing missed diagnoses across a high volume of ECGs.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	LINQ II Insertable Cardiac Monitor	DeepRhythmAI
Pricing	Enterprise	Enterprise
Deployment	Hybrid	Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Tool A (LINQ II) offers a patient-facing mobile app (MyCareLink Heartu2122) and remote programming capabilities, enhancing direct patient and clinician interaction for device management and data transmission. Tool B is cloud-based and device-agnostic but lacks a direct mobile app for patient engagement, making Tool A more directly user-friendly for patients.

Clinical Value

DeepRhythmAI

Tool B (DeepRhythmAI) provides specific, quantifiable metrics for reducing missed diagnoses (14x to 114x fewer) and increasing workflow efficiency (up to 65%), backed by advanced AI models (CNN and Transformer) and a massive training dataset (250 billion+ heartbeats). While Tool A offers long-term monitoring and pediatric indication, Tool B's claims are more directly tied to improved diagnostic outcomes and operational efficiency through its core AI analysis.

Pricing & Value

DeepRhythmAI

Both tools operate on an enterprise pricing model with no public disclosure, making a direct price comparison impossible. However, DeepRhythmAI's stated benefits of significantly reduced missed diagnoses and increased workflow efficiency offer a clearer, quantifiable path to demonstrating return on investment for healthcare systems, suggesting a stronger value proposition despite unknown pricing.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic (Tool A) is a globally recognized, long-established medical device company with a vast installed base of over a million patients for its ICMs, demonstrating extensive experience, regulatory navigation, and trust within the healthcare enterprise. While Tool B is FDA-cleared and cloud-based, Medtronic's sheer scale, history, and hybrid deployment option provide a stronger indicator of enterprise readiness.

Innovation

DeepRhythmAI

Tool B (DeepRhythmAI) showcases innovation through its explicit use of advanced AI models (CNN and Transformer) trained on an exceptionally large dataset (250 billion+ heartbeats) and its device-agnostic integration for ECG analysis. Tool A's innovation focuses on remote programming and specific algorithms for an insertable device, but Tool B's core AI technology appears more broadly groundbreaking in the field of ECG data interpretation.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic (Tool A) provides comprehensive support resources, including dedicated technical and patient service phone lines, detailed device manuals, patient guides, and online resources for its LINQ II system. In contrast, information regarding specific support channels and extensive documentation for DeepRhythmAI is less publicly detailed, suggesting a more robust and transparent support infrastructure for Tool A.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	LINQ II Insertable Cardiac Monitor	DeepRhythmAI
Product Name	LINQ II Insertable Cardiac Monitor	DeepRhythmAI
Company	Medtronic	Medicalgorithmics S.A.
Mobile App	both (MyCareLink Heartu2122 mobile app for data transmission)	none
Key AI Technology	AccuRhythmu2122 AI algorithms for enhanced accuracy, Innovative PVC detection algorithm	AI-powered arrhythmia detection and classification, Utilizes CNN and Transformer models, Trained on 250 billion+ annotated heartbeats
Monitoring/Analysis Scope	Up to 4.5 years of continuous monitoring (insertable cardiac monitor)	Cardiac arrhythmia detection and classification from ECG data (cloud-based AI algorithm)
Data Export	yes	yes

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and DeepRhythmAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in how these tools acquire and analyze cardiac rhythm data?

The Medtronic LINQ II is an insertable cardiac monitor that continuously collects heart rhythm data for up to 4.5 years. In contrast, DeepRhythmAI is a cloud-based AI algorithm designed to analyze existing ECG data from various external devices.

How do the AI capabilities of each tool differ in their application?

LINQ II utilizes AccuRhythm AI algorithms to enhance the accuracy of arrhythmia detection from its continuously collected data. DeepRhythmAI, on the other hand, employs CNN and Transformer models, trained on over 250 billion heartbeats, to detect and classify arrhythmias from ECG data provided by other devices.

Can these tools be used for pediatric patients?

The Medtronic LINQ II has a pediatric indication for patients aged 2 and older who require long-term, continuous monitoring for heart rhythm abnormalities. DeepRhythmAI's intended use specifies that it assesses cardiac arrhythmias using ECG data from adult patients.

How do these tools address workflow efficiency and diagnostic accuracy?

LINQ II aims for enhanced accuracy through its AI algorithms and continuous, long-term monitoring for diagnosis. DeepRhythmAI claims to streamline clinical workflows by up to 65% and reduce missed critical arrhythmia diagnoses by 14 times compared to technician analysis, offering faster ECG reporting and analysis.

What are the key differences in data handling and integration?

LINQ II collects data directly from the implanted device and transmits it via its dedicated app or home communicator, with data export capabilities. DeepRhythmAI is device-agnostic, integrating with various ECG devices through its cloud-based software and offering an API for data export.

What is the long-term monitoring capability of each solution?

The Medtronic LINQ II provides continuous heart rhythm monitoring for an extended period of up to 4.5 years. DeepRhythmAI analyzes ECG data from various devices, but its description does not specify a continuous long-term monitoring duration as it processes data from external sources.}